Endoscopic management of ampullary tumors: European Society of
Gastrointestinal Endoscopy (ESGE) Guideline

J 2021

Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

VANBIERVLIET, G., M. STRIJKER, M. ARVANITAKIS, A. AELVOET, U. ARNELO et. al.

Basic information

Original name

Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Authors

VANBIERVLIET, G. (guarantor), M. STRIJKER, M. ARVANITAKIS, A. AELVOET, U. ARNELO, T. BEYNA, O. BUSCH, P. H. DEPREZ, Lumír KUNOVSKÝ (203 Czech Republic, belonging to the institution), A. LARGHI, G. MANES, A. MOSS, B. NAPOLEON, M. NAYAR, E. PEREZ-CUADRADO-ROBLES, S. SEEWALD, M. BARTHET and J. E. VAN HOOFT

Edition

Endoscopy, STUTTGART, GEORG THIEME VERLAG KG, 2021, 0013-726X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30212 Surgery

Country of publisher

Germany

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 9.776

RIV identification code

RIV/00216224:14110/21:00121429

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1055/a-1397-3198

UT WoS

000629334400001

Keywords in English

ampullary tumors; endoscopic management

Abstract

V originále

Main Recommendations 1 ESGE recommends against diagnostic/therapeutic papillectomy when adenoma is not proven. Strong recommendation, low quality evidence. 2 ESGE recommends endoscopic ultrasound and abdominal magnetic resonance cholangiopancreatography (MRCP) for staging of ampullary tumors. Strong recommendation, low quality evidence. 3 ESGE recommends endoscopic papillectomy in patients with ampullary adenoma without intraductal extension, because of good results regarding outcome (technical and clinical success, morbidity, and recurrence). Strong recommendation, moderate quality evidence. 4 ESGE recommends en bloc resection of ampullary adenomas up to 20-30mm in diameter to achieve R0 resection, for optimizing the complete resection rate, providing optimal histopathology, and reduction of the recurrence rate after endoscopic papillectomy. Strong recommendation, low quality evidence. 5 ESGE suggests considering surgical treatment of ampullary adenomas when endoscopic resection is not feasible for technical reasons (e.g. diverticulum, size >4cm), and in the case of intraductal involvement (of >20mm). Surveillance thereafter is still mandatory. Weak recommendation, low quality evidence. 6 ESGE recommends direct snare resection without submucosal injection for endoscopic papillectomy. Strong recommendation, moderate quality evidence. 7 ESGE recommends prophylactic pancreatic duct stenting to reduce the risk of pancreatitis after endoscopic papillectomy. Strong recommendation, moderate quality evidence. 8 ESGE recommends long-term monitoring of patients after endoscopic papillectomy or surgical ampullectomy, based on duodenoscopy with biopsies of the scar and of any abnormal area, within the first 3 months, at 6 and 12 months, and thereafter yearly for at least 5 years. Strong recommendation, low quality evidence.

Citovat

VANBIERVLIET, G., M. STRIJKER, M. ARVANITAKIS, A. AELVOET, U. ARNELO, T. BEYNA, O. BUSCH, P. H. DEPREZ, Lumír KUNOVSKÝ, A. LARGHI, G. MANES, A. MOSS, B. NAPOLEON, M. NAYAR, E. PEREZ-CUADRADO-ROBLES, S. SEEWALD, M. BARTHET and J. E. VAN HOOFT. Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. STUTTGART: GEORG THIEME VERLAG KG, 2021, vol. 53, No 04, p. 429-448. ISSN 0013-726X. Available from: https://dx.doi.org/10.1055/a-1397-3198.

@article{1761817,
   author = {Vanbiervliet, G. and Strijker, M. and Arvanitakis, M. and Aelvoet, A. and Arnelo, U. and Beyna, T. and Busch, O. and Deprez, P. H. and Kunovský, Lumír and Larghi, A. and Manes, G. and Moss, A. and Napoleon, B. and Nayar, M. and PerezandCuadradoandRobles, E. and Seewald, S. and Barthet, M. and van Hooft, J. E.},
   article_location = {STUTTGART},
   article_number = {04},
   doi = {http://dx.doi.org/10.1055/a-1397-3198},
   keywords = {ampullary tumors; endoscopic management},
   language = {eng},
   issn = {0013-726X},
   journal = {Endoscopy},
   title = {Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline},
   url = {https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1397-3198},
   volume = {53},
   year = {2021}
}

TY  - JOUR
ID  - 1761817
AU  - Vanbiervliet, G. - Strijker, M. - Arvanitakis, M. - Aelvoet, A. - Arnelo, U. - Beyna, T. - Busch, O. - Deprez, P. H. - Kunovský, Lumír - Larghi, A. - Manes, G. - Moss, A. - Napoleon, B. - Nayar, M. - Perez-Cuadrado-Robles, E. - Seewald, S. - Barthet, M. - van Hooft, J. E.
PY  - 2021
TI  - Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
JF  - Endoscopy
VL  - 53
IS  - 04
SP  - 429-448
EP  - 429-448
PB  - GEORG THIEME VERLAG KG
SN  - 0013726X
KW  - ampullary tumors
KW  - endoscopic management
UR  - https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1397-3198
N2  - Main Recommendations 1 ESGE recommends against diagnostic/therapeutic papillectomy when adenoma is not proven. Strong recommendation, low quality evidence. 2 ESGE recommends endoscopic ultrasound and abdominal magnetic resonance cholangiopancreatography (MRCP) for staging of ampullary tumors. Strong recommendation, low quality evidence. 3 ESGE recommends endoscopic papillectomy in patients with ampullary adenoma without intraductal extension, because of good results regarding outcome (technical and clinical success, morbidity, and recurrence). Strong recommendation, moderate quality evidence. 4 ESGE recommends en bloc resection of ampullary adenomas up to 20-30mm in diameter to achieve R0 resection, for optimizing the complete resection rate, providing optimal histopathology, and reduction of the recurrence rate after endoscopic papillectomy. Strong recommendation, low quality evidence. 5 ESGE suggests considering surgical treatment of ampullary adenomas when endoscopic resection is not feasible for technical reasons (e.g. diverticulum, size >4cm), and in the case of intraductal involvement (of >20mm). Surveillance thereafter is still mandatory. Weak recommendation, low quality evidence. 6 ESGE recommends direct snare resection without submucosal injection for endoscopic papillectomy. Strong recommendation, moderate quality evidence. 7 ESGE recommends prophylactic pancreatic duct stenting to reduce the risk of pancreatitis after endoscopic papillectomy. Strong recommendation, moderate quality evidence. 8 ESGE recommends long-term monitoring of patients after endoscopic papillectomy or surgical ampullectomy, based on duodenoscopy with biopsies of the scar and of any abnormal area, within the first 3 months, at 6 and 12 months, and thereafter yearly for at least 5 years. Strong recommendation, low quality evidence.
ER  -

VANBIERVLIET, G., M. STRIJKER, M. ARVANITAKIS, A. AELVOET, U. ARNELO, T. BEYNA, O. BUSCH, P. H. DEPREZ, Lumír KUNOVSKÝ, A. LARGHI, G. MANES, A. MOSS, B. NAPOLEON, M. NAYAR, E. PEREZ-CUADRADO-ROBLES, S. SEEWALD, M. BARTHET and J. E. VAN HOOFT. Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. \textit{Endoscopy}. STUTTGART: GEORG THIEME VERLAG KG, 2021, vol.~53, No~04, p.~429-448. ISSN~0013-726X. Available from: https://dx.doi.org/10.1055/a-1397-3198.

Detailed Information on Publication Record